FDA Approves Centuries-Old Blood Treatment for Critical Coronavirus Patients
EXCERPTS...
* The FDA added that convalescent plasma can be collected only from individuals who are eligible to donate blood and who have fully recovered from the coronavirus infection.
* “I think we don’t know until we have experience and case reports with this particular disease whether it will be effective, but just based on its track record with a number of other viruses, I think it has a very good chance of working,” the doctor added.